Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013 Jul 11; 369(2):134-44.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antineoplastic Agents
Brain Neoplasms
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Melanoma
Middle Aged
Skin Neoplasms
authors with profiles
Frank Stephen Hodi, M.D.
Xiaoyu Li, Ph.D., M.D.